Laboratory of Clinical Investigation
Josephine Egan, MD, Chief
The Laboratory of Clinical Investigation (LCI) is comprised of 3 Sections with 4 principal investigators. These are as follows: Bioanalytical Chemistry and Drug Discovery Section; Diabetes Section; and Magnetic Resonance Imaging and Spectroscopy Section. The common theme and thread among these research groups is that of the identification and development of new therapeutic targets for the treatment of age-related disease. The Laboratory serves as an infrastructure to facilitate the creation and development of therapeutic targets within the Laboratory and across the Intramural Research Program.
- Bioanalytical Chemistry
- Drug Discovery
- Magnetic Resonance Imaging and Spectroscopy